Cargando…

A toxic subset of soluble α-synuclein species in dementia with Lewy body

This scientific commentary refers to ‘Analysis of α-synuclein species enriched from cerebral cortex of humans with sporadic dementia with Lewy bodies’, by Sanderson et al. (https://doi.org/10.1093/braincomms/fcaa010).

Detalles Bibliográficos
Autor principal:	Castillo-Carranza, Diana L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Scientific Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425380/ https://www.ncbi.nlm.nih.gov/pubmed/32954281 http://dx.doi.org/10.1093/braincomms/fcaa016

Ejemplares similares

α‐Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies
por: van Steenoven, Inger, et al.
Publicado: (2018)

α-Synuclein as CSF and Blood Biomarker of Dementia with Lewy Bodies
por: Kasuga, Kensaku, et al.
Publicado: (2012)

Analysis of α-synuclein species enriched from cerebral cortex of humans with sporadic dementia with Lewy bodies
por: Sanderson, John B, et al.
Publicado: (2020)

Network dysfunction in α‐synuclein transgenic mice and human Lewy body dementia
por: Morris, Meaghan, et al.
Publicado: (2015)

α-Synuclein-mediated neurodegeneration in Dementia with Lewy bodies: the pathobiology of a paradox
por: Simon, Christopher, et al.
Publicado: (2021)

Quantifying regional α ‐synuclein, amyloid β, and tau accumulation in lewy body dementia
por: Miller, Rebecca L., et al.
Publicado: (2022)

Brain-derived exosomes from dementia with Lewy bodies propagate α-synuclein pathology
por: Ngolab, Jennifer, et al.
Publicado: (2017)

Decreased DHA‐containing phospholipids in the neocortex of dementia with Lewy bodies are associated with soluble Aβ(42), phosphorylated α‐synuclein, and synaptopathology
por: Chong, Joyce R., et al.
Publicado: (2023)

The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementia
por: Schulz-Schaeffer, Walter J.
Publicado: (2010)

Accumulation of α-synuclein in dementia with Lewy bodies is associated with decline in the α-synuclein-degrading enzymes kallikrein-6 and calpain-1
por: Miners, J Scott, et al.
Publicado: (2014)

Different α-synuclein prion strains cause dementia with Lewy bodies and multiple system atrophy
por: Ayers, Jacob I., et al.
Publicado: (2022)

Small soluble α-synuclein aggregates are the toxic species in Parkinson’s disease
por: Emin, Derya, et al.
Publicado: (2022)

Correction to: Brain-derived exosomes from dementia with Lewy bodies propagate α-synuclein pathology
por: Ngolab, Jennifer, et al.
Publicado: (2020)

Altered Serum IgG Levels to α-Synuclein in Dementia with Lewy Bodies and Alzheimer’s Disease
por: Koehler, Niklas K. U., et al.
Publicado: (2013)

α‐Synuclein RT‐QuIC assay in cerebrospinal fluid of patients with dementia with Lewy bodies
por: Bongianni, Matilde, et al.
Publicado: (2019)

α-Synuclein Strains and Their Relevance to Parkinson’s Disease, Multiple System Atrophy, and Dementia with Lewy Bodies
por: Graves, Noah J., et al.
Publicado: (2023)

α-Synuclein Oligomers Induce a Unique Toxic Tau Strain
por: Castillo-Carranza, Diana L., et al.
Publicado: (2018)

Prion-Like Seeding of Misfolded α-Synuclein in the Brains of Dementia with Lewy Body Patients in RT-QUIC
por: Sano, Kazunori, et al.
Publicado: (2017)

Unique α-synuclein pathology within the amygdala in Lewy body dementia: implications for disease initiation and progression
por: Sorrentino, Zachary A., et al.
Publicado: (2019)

Differential insular cortex subregional vulnerability to α‐synuclein pathology in Parkinson's disease and dementia with Lewy bodies
por: Fathy, Y. Y., et al.
Publicado: (2018)

The challenges of COVID‐19 for people with dementia with Lewy bodies and family caregivers
por: Killen, Alison, et al.
Publicado: (2020)

Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson’s disease with dementia and dementia with Lewy bodies compared to Alzheimer’s disease
por: Hansson, Oskar, et al.
Publicado: (2014)

Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson’s disease and dementia with Lewy bodies
por: Stuendl, Anne, et al.
Publicado: (2016)

Nasal Rifampicin Improves Cognition in a Mouse Model of Dementia with Lewy Bodies by Reducing α-Synuclein Oligomers
por: Umeda, Tomohiro, et al.
Publicado: (2021)

Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies
por: Koss, David J., et al.
Publicado: (2022)

α-Synuclein aggregates amplified from patient-derived Lewy bodies recapitulate Lewy body diseases in mice
por: Uemura, Norihito, et al.
Publicado: (2023)

Hippocampal neuronal cells that accumulate α-synuclein fragments are more vulnerable to Aβ oligomer toxicity via mGluR5 – implications for dementia with Lewy bodies
por: Overk, Cassia R, et al.
Publicado: (2014)

Distinct biological activity of Lewy body α-Synuclein strain in mice
por: Uemura, Norihito, et al.
Publicado: (2023)

Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy
por: Gerson, Julia E., et al.
Publicado: (2018)

Longitudinal live imaging of retinal α-synuclein::GFP deposits in a transgenic mouse model of Parkinson’s Disease/Dementia with Lewy Bodies
por: Price, Diana L., et al.
Publicado: (2016)

Lewy body disease and dementia with Lewy bodies
por: KOSAKA, Kenji
Publicado: (2014)

Evaluating the relationship between amyloid-β and α-synuclein phosphorylated at Ser129 in dementia with Lewy bodies and Parkinson’s disease
por: Swirski, Marta, et al.
Publicado: (2014)

Human Neural Progenitor Transplantation Rescues Behavior and Reduces α‐Synuclein in a Transgenic Model of Dementia with Lewy Bodies
por: Goldberg, Natalie R.S., et al.
Publicado: (2017)

The Contribution of Tau, Amyloid-Beta and Alpha-Synuclein Pathology to Dementia in Lewy Body Disorders
por: Irwin, David J., et al.
Publicado: (2018)

Alpha-synuclein seeds in olfactory mucosa and cerebrospinal fluid of patients with dementia with Lewy bodies
por: Perra, Daniela, et al.
Publicado: (2021)

Structure of alpha-synuclein fibrils derived from human Lewy body dementia tissue
por: Dhavale, Dhruva D., et al.
Publicado: (2023)

Absence of Alpha-Synuclein Pathology in the Stomach of a Patient With Prodromal Dementia With Lewy Bodies
por: Shin, Chaewon, et al.
Publicado: (2023)

TREM2 p.R47H substitution is not associated with dementia with Lewy bodies
por: Walton, Ronald L., et al.
Publicado: (2016)

Selectivity of Lewy body protein interactions along the aggregation pathway of α-synuclein
por: Leitão, André D. G., et al.
Publicado: (2021)

Alpha-synuclein biology in Lewy body diseases
por: Kim, Woojin Scott, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_euqalq1f4d41tvatld28bovv89